Implemeting ADCC assays in QC: When donor variability isn’t an option

Watch our on-demand webinar about single donor-derived KILR CD16 Effector Cells to ensure assay reproductibility for screening, characterization, and QC lot release antibody drugs. Presented by our expert scientists, Lisa Blackwood and Laura Munro, and co-hosted with DiscoverX. The webinar focuses on 2 qualification studies that were performed using these effectors to demonstrate accuracy and precision in different More

Biosimilars: Lessons Learned

A Quality by Design approach to de-risk biosimilar development Learn more about the evolving biosimilar development pathway and how a QbD approach ensures a step-wise, orthogonal process to de-risk development and improve speed to market. Watch on demand now

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

Sign-up to receive 3 tips on improving
speed to clinic for biosimilars

* you agree to receive emails with tips, news, insights and quizzes.